Bain Capital Public Equity Management’s PTC Therapeutics PTCT Stock Holding History

Bain Capital Public Equity Management’s Portfolio PTCT Stock Details PTCT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q4	–	Sell	-906,201	Closed	-$24.2M	–	37
2015 Q3	$24.2M	Sell	906,201 -132,154	-13%	-$5.65M	0.72%	32
2015 Q2	$50M	Sell	1,038,355 -612,980	-37%	-$35.8M	1.3%	27
2015 Q1	$100M	Sell	1,651,335 -430,597	-21%	-$26.3M	2.5%	17
2014 Q4	$108M	Sell	2,081,932 -780,093	-27%	-$34.3M	2.7%	14
2014 Q3	$126M	Hold	2,862,025	–	–	3.23%	9
2014 Q2	$74.8M	Hold	2,862,025	–	–	1.81%	21
2014 Q1	$74.8M	Buy	2,862,025 +444,490	+18%	+$11.9M	1.99%	22
2013 Q4	$41M	Buy	2,417,535 +84,202	+4%	+$1.48M	1.16%	34
2013 Q3	$50.1M	Buy	+2,333,333	New	+$40.6M	1.26%	31

Other funds holding PTCT

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Westfield Capital Management

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return